Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
Children's Mercy Hospital, Kansas City, Missouri.
Arthritis Care Res (Hoboken). 2022 Mar;74(3):355-363. doi: 10.1002/acr.24491. Epub 2022 Feb 9.
The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire measures vision-related functioning (VRF) and vision-related quality of life (VRQoL) in children with uveitis. Our aim was to revise the alpha version of the EYE-Q to refine VRF and VRQoL subscales and to assess the validity of the EYE-Q.
Children with juvenile idiopathic arthritis (JIA), JIA-associated uveitis, and other noninfectious uveitis were enrolled. Patients and parents completed the EYE-Q, Pediatric Quality of Life Inventory (overall quality of life), and Childhood Health Assessment Questionnaire (physical functioning). The development site completed the alpha version of the EYE-Q, and the composite sites completed the beta version. We compared item-subscale correlations, internal consistency, and construct and discriminant validity among the different versions.
Of the 644 patients enrolled, 61.6% completed the alpha version, and 38.4% the beta version of the EYE-Q. Mean ± SD patient age was 11.1 ± 4.2 years, and 70% were female. Fewer White patients (73.5%) completed the alpha version compared to the beta version (86.2%; P < 0.001). With the exception of patient-reported VRF, both versions had similar item-subscale correlations. Version comparisons on scale internal consistencies indicated significant differences for parent- and patient-reported VRF, but each scale had a Cronbach's α of >0.80 beta. When data were combined, the EYE-Q showed significant differences between JIA-only and uveitis patients on all parent and patient scores, except for patient-reported VRF.
The EYE-Q appears to be a valid measure of VRF and VRQoL in pediatric uveitis. Our results suggest it may be used as an outcome measure in multicenter pediatric uveitis studies.
青少年视力对生活质量的影响(EYE-Q)问卷用于评估葡萄膜炎患儿的视力相关功能(VRF)和视力相关生活质量(VRQoL)。我们的目标是修订 EYE-Q 的 alpha 版本,以完善 VRF 和 VRQoL 分量表,并评估 EYE-Q 的有效性。
入组了幼年特发性关节炎(JIA)、JIA 相关性葡萄膜炎和其他非感染性葡萄膜炎患儿。患者和家长完成了 EYE-Q、儿科生活质量问卷(整体生活质量)和儿童健康评估问卷(身体功能)。开发地点完成了 EYE-Q 的 alpha 版本,综合地点完成了 beta 版本。我们比较了不同版本的条目-分量表相关性、内部一致性以及结构和判别有效性。
644 名患儿中,61.6%完成了 EYE-Q 的 alpha 版本,38.4%完成了 beta 版本。患儿平均年龄为 11.1±4.2 岁,70%为女性。与 beta 版本(86.2%)相比,完成 alpha 版本的白人患儿(73.5%)较少(P<0.001)。除了患者报告的 VRF 外,两个版本的条目-分量表相关性相似。在尺度内部一致性的版本比较中,父母和患者报告的 VRF 存在显著差异,但每个尺度的 Cronbach's α 均>0.80 beta。当数据合并时,EYE-Q 在所有父母和患者评分中,除了患者报告的 VRF 外,JIA 仅和葡萄膜炎患者之间存在显著差异。
EYE-Q 似乎是一种用于评估儿童葡萄膜炎 VRF 和 VRQoL 的有效工具。我们的研究结果表明,它可作为多中心儿童葡萄膜炎研究的结局指标。